Okyo Pharma Ltd. (OKYO)
NASDAQ · Healthcare
Okyo Pharma Ltd. Shareholder Equity 2020–2025
Okyo Pharma Ltd. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Okyo Pharma Ltd. shareholder equity as of March 31, 2025: -5.5M, a 5.61% decrease year-over-year.
- Okyo Pharma Ltd. shareholder equity for 2025 were -5.5M, a 5.61% decrease from 2024.
- Okyo Pharma Ltd. shareholder equity for 2024 were -5.9M, a 186.36% increase from 2023.
- Okyo Pharma Ltd. shareholder equity for 2023 were -2.1M, a 193.50% decrease from 2022.
- Okyo Pharma Ltd. shareholder equity for 2022 were 2.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Okyo Pharma Ltd. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-6 |
| 2024 | $-6 |
| 2023 | $-2 |
| 2022 | $2 |
| 2021 | $5 |
| 2020 | $-0 |
Okyo Pharma Ltd. Shareholder Equity — FAQ
Okyo Pharma Ltd. (OKYO) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OKYO's shareholder equity history?
The chart and table above show Okyo Pharma Ltd.'s shareholder equity by year and by quarter, including the growth rate.